Samuel Case, FISM News
On Friday the FDA approved the Pfizer / BioNTech vaccine for emergency use authorization. The move may mark the beginning of the end of the COVID-19 pandemic in the United States. Over the weekend hospitals across the country prepared for the vaccine rollout. Roughly 2.9 million doses are in the first shipment.
📸: The first shipment from our Kalamazoo plant. @UPS @FedEx
The Pfizer-BioNTech #COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16+. See conditions of use: https://t.co/OS1tgYopUj pic.twitter.com/yogti0Ahcq
— Pfizer Inc. (@pfizer) December 13, 2020
First in the line for the long awaited shot will be health care workers and those in nursing homes. Pfizer CEO Albert Bourla told CNN that he too will be among the first to take the vaccine to give the public confidence in its safety
Operation Warp Speed chief adviser Dr. Moncef Slaoui told Fox News that more than 100 million Americans could have the two dose shot by the end of March 2021. Slaoui also said he believes the U.S. will have vaccinated 20 million people by the end of the year.
Moderna’s vaccine will undergo the same regulatory review as Pfizer’s this week and could be given the green light as early as this weekend. The U.S. government has ordered 200 million doses of the Moderna shot, about 20 million of which will be delivered by the end of the year.